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Enterotoxigenic Escherichia coli (ETEC) are ubiquitous diarrheal pathogens that thrive in areas lacking basic human needs of clean
water and sanitation. These genetically plastic organisms cause tremendous morbidity among disadvantaged young children, in
the form of both acute diarrheal illness and sequelae of malnutrition and growth impairment. The recent discovery of additional
plasmid-encoded virulence factors and elucidation of their critical role in the molecular pathogenesis of ETEC may inform new approaches to the development of broadly protective vaccines. Although the pathogens have been closely linked epidemiologically with
nondiarrheal sequelae, these conditions remain very poorly understood. Similarly, while canonical effects of ETEC toxins on cellular
signaling promoting diarrhea are clear, emerging data suggest that these toxins may also drive changes in intestinal architecture and
associated sequelae. Elucidation of molecular events underlying these changes could inform optimal approaches to vaccines that
prevent acute diarrhea and ETEC-associated sequelae.
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The enterotoxigenic Escherichia coli are common pathogens that
comprise a genetically diverse diarrheagenic E. coli pathovar
defined by the production of heat-labile toxin (LT) and/or
heat-stable toxin (ST). It is estimated that worldwide hundreds
of millions of symptomatic enterotoxigenic E. coli (ETEC) infections occur annually [1], a burden predominantly borne by
young children of low-middle-income countries. Here, ETEC
remain a major cause of deaths due to acute diarrheal illness.
Abundant in low-middle-income regions where clean water
and sanitation remain limited, ETEC are perennially the most
common pathogen isolated from travelers with infectious diarrhea. Surprisingly, however, they have also been associated with
outbreaks [2, 3] and sporadic cases in more developed areas,
including the United States, where recently introduced cultureindependent methods may accelerate their identification [4, 5].
CANONICAL VIEW OF ETEC VIRULENCE

These pathogens were originally identified now >5 decades ago
in patients presenting with severe choleralike diarrheal syndromes [6]. Early investigation in these patients with non-Vibrio
cholera in India and Bangladesh soon revealed the presence
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of E. coli that produced a heat-labile toxin (LT) LT similar to
cholera toxin, and subsequently the small peptide STs, as well
as the first of many plasmid-encoded fimbrial colonization factors (CFs). A canonical view of ETEC virulence soon evolved,
in which these pathogens simply adhere to intestine via CFs to
deliver their toxin payloads, and much of the ensuing investigation of ETEC related to discovery and characterization of
additional plasmid-encoded CFs or coli surface (CS) antigens.
To date, >25 antigenically distinct CF/CS antigens have been
defined. Elucidation of the structural biology and biogenesis of
these antigens suggests that development of a broadly protective
vaccine would require a multivalent approach incorporating
multiple adhesins and toxoid molecules [7]. Approaches to vaccine development have focused primarily on these antigens and
LT. Nevertheless, data generated over the past few years have
highlighted major gaps in our understanding of these extraordinarily common pathogens to demonstrate that ETEC are far
more complex than had been appreciated.
ESSENTIAL ELEMENTS OF ETEC AS A SUCCESSFUL
PATHOGEN

In effect, ETEC molecular pathogenesis can be viewed as the
summary of events that enable these bacteria to reach the small
intestine, traffic to the mucosal surface, engage epithelial cell
receptors and ultimately deliver their LT and/or ST payloads.
This process ultimately requires a coordinated division of labor
between highly conserved core elements encoded the E. coli
chromosome and the ETEC pathovar-specific features encoded
on virulence plasmids [8].
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Emerging Themes in the Molecular Pathogenesis of
Enterotoxigenic Escherichia coli

IMPORTANCE OF CHROMOSOMALLY ENCODED
VIRULENCE TRAITS

IDENTIFYING AND CHARACTERIZING ADDITIONAL
PLASMID-ENCODED ETEC VIRULENCE FACTORS

The identification of additional surface-expressed antigens
has expanded the repertoire of ETEC virulence factors and
contributed to our understanding of ETEC molecular pathogenesis. Two plasmid-encoded loci, discovered in a search for
novel secreted molecules, have emerged as important virulence
Table 1.

Enterotoxigenic Escherichia coli Virulence Factors

Gene Location

Description and Known Dominant Functions

ETEC
Specific?

CFs/CS antigens

Plasmid

Fimbrial and afimbrial structures that promote adhesion and small-intestinal colonization

Yes

LT

Plasmid

ADP ribosylating toxin, activates cAMP production to alter ion channels

Yes

STs (STh and STp)

Plasmid

Binds guanylate cyclase C to activate cGMP production to alter ion channels

Yes

Virulence Factor/Locus
Canonical ETEC virulence traits

Chromosomally encoded
Escherichia coli virulence traits
Flagella

Chromosome

Motility; essential for toxin delivery

No

Type 1 pili

Chromosome

Adhesion to mannosylated glycoproteins

No

EaeH

Chromosome

Outer membrane protein/adhesin

No

YghJ

Chromosome

Metalloprotease

No

T2SS

Chromosome

Responsible for secretion of LT and YghJ

No

TolC T1SS

Chromosome

Responsible for secretion of STh and STp

No

EatA

Plasmid

Mucin-degrading serine protease autotransporter protein

Yesa

EtpB, EtpA, EtpC

Plasmid

2-Partner secretion system responsible for export of EtpA, an extracellular adhesin that
binds to GalNAc and blood group A glycans

Yes

Noncanonical ETEC virulence
factors

Abbreviations: ADP, adenosine diphosphate; cAMP, cyclic adenosine monophosphate; CFs, colonization factors; cGMP, cyclic guanosine monophosphate; CS, coli surface; EatA, ETEC
autotransporter A; ETEC, enterotoxigenic Escherichia coli; GalNAc, N-acetylgalactosamine; LT, heat-labile toxin; STs, heat-stable toxins; T1SS, type I secretion system; T2SS type II secretion
system.
a

Also found in some Shigella spp., including Shigella sonnei.
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With time, it has become clear that ETEC rely on a number of
chromosomally encoded features. Virtually all ETEC are motile
and can be serotyped according to their flagellar H antigens,
and flagellar motility is essential to successful delivery of both
LT and ST. The flagellar assembly apparatus is encoded on the
chromosome, as are genes encoding type 1 pili common to
all E. coli [9], and those encoding additional outer membrane
surface adhesins [10]. Likewise, although the toxins that define ETEC are plasmid encoded, the type II secretion system
for LT [11], and the type I TolC secretion system responsible
for export of ST [12] are both encoded on the chromosome.
Remarkably, before the discovery of its cognate export system,
ETEC were thought to simply release LT by lysis, as expression
of the structurally similar cholera toxin in a laboratory strain
of E. coli (which happened to lack the type II secretion system)
failed to export the toxin. Fortunately, we now know that these
chromosomally encoded features work in a highly orchestrated
and cooperative fashion [8] with plasmid-borne pathovarspecific virulence traits to facilitate toxin delivery (Table 1).

factors. These include EatA, a member of the serine protease
autotransporter of the Enterobactericiae family [13], and the
etpBAC 2-partner secretion locus responsible for export of
EtpA, an extracellular adhesin [14]. (Figure 1)
Although the layer of secreted mucin in the small intestine
is relatively thin compared with that in the colon, it is likely
that this effectively prevents effective engagement by pathogenic bacteria including ETEC, and that LT, like cholera toxin,
can induce the production and release of mucin from goblet
cells. Studies have shown that the secreted passenger domain
of EatA, which contains both mucin-binding activity as well as
the serine protease catalytic triad, degrades MUC2, the major
mucin secreted by intestinal goblet cells.
MUC2 is a very large glycoprotein that has been dimerized
at its C-terminal end and is thought to form complex trimeric
structures at the N-terminus of the molecule. This results in
hexameric arrays of MUC2 arranged in sheets [15] that in effect trap the bacteria and prevent pathogen-host engagement.
Data emerging from EatA-mediated degradation of MUC2 suggest that this conserved protease, as well as SepA, a homologous
protein from Shigella flexneri, work by cleaving MUC2 to effectively dissolve the protective sheets of mucin. ETEC equipped
with EatA can therefore overcome the mucin barrier, allowing
these pathogens to engage in productive pathogen-host interactions essential for toxin delivery [16].
EtpA promotes these interactions by acting as a molecular
bridge [17] between the bacteria and host cell glycans present
on mucins [18] and intestinal epithelial cells. Like a host of bacterial adhesins, including another 2-partner secretion protein,
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Figure 1. Summary of steps in the molecular pathogenesis of enterotoxigenic Escherichia coli (ETEC). Step 1: ETEC are propelled to the small-intestinal lumen via
peritrichous flagella. Step 2: ETEC engage the mucin overlying small-intestinal epithelia cells, in part mediated by EtpA bridging of the bacterial flagella with glycans present
in mucin. Step 3: Degradation of MUC2 by the proteolytically active EatA passenger domain (EatAp) permits bacterial access to the epithelial surface. Steps 4 and 5: ETEC
engage enterocytes via plasmid-encoded colonization factor molecules in addition to EtpA, where delivery of heat-labile toxin (LT) activates production of cellular cyclic adenosine monophosphate (cAMP), which in turn activates protein kinase A (PKA). PKA catalytic subunits phosphorylates sodium (Na+) and chloride (Cl−) channels, resulting in the
net export of salt and water into the intestinal lumen and diarrhea. PKA also phosphorylates other cellular target proteins, and enters the nucleus to alter transcription via
cAMP response element (CRE) binding protein (CREB). Step 6: Heat-stable toxin (ST) binds to guanylate cyclase C to elicit the production of cyclic guanosine monophosphate
(cGMP), activating protein kinase G (PKG), which phosphorylates ion channel proteins and other targets. Steps 7–9: LT modulates the transcription of multiple genes including
those encoding CEACAMs, which that then serve as receptors for ETEC expressing type 1 fimbriae and MUC2 enhancing the mucin barrier. Abbreviation: H+, . (Figure created
with BioRender.com.)

filamentous hemagglutinin of Bordetella pertussis, part of acellular pertussis vaccines, EtpA also possesses hemagglutinating
activity. In the case of EtpA, this activity is very specific for
human A blood group erythrocytes. Because blood group
A glycans are also present on intestinal epithelia, the preferential binding of EtpA may explain observations of more severe
illness observed among those in blood group A+, including naturally infected young children [19] and human volunteers challenged with ETEC [20].
Several findings attest to the importance of these more recently discovered “noncanonical” virulence proteins in the molecular pathogenesis of ETEC. First, both antigens discovered
in ETEC H10407 [13, 14], an early isolate from a patient with
severe choleralike diarrhea, have been identified in multiple
isolates from severe diarrheal illness, and they are conserved
and have been retained over time among a large and geographically dispersed population of ETEC [21–24]. Both antigens
are highly immunogenic in human volunteers challenged with
H10407 [25, 26] and naturally infected hosts [24] suggesting
that they are expressed in vivo. Notably, recent analysis of strains
obtained from a birth cohort of young children in Bangladesh
indicate that both molecules are significantly associated with

symptomatic infection [27]. Conversely, antibodies against either antigen were associated with asymptomatic colonization.
Collectively, the data emerging from molecular pathogenesis as
well as clinical studies seem to support a role for these recently
discovered “noncanonical” antigens in virulence.
POTENTIAL IMPORTANCE OF NONCANONICAL
ANTIGENS AS VACCINE TARGETS

These recent studies of ETEC molecular pathogenesis may
afford new approaches to the development of a broadly protective vaccine. The conservation of these more recently discovered highly immunogenic molecules suggests that they may
provide alternative targets for vaccine development. Recently,
available ETEC genomes were mined to identify potential
surface antigens that were conserved in at least 40% of isolates, and these were then spotted onto protein microarrays to
identify those recognized during the course of infection [27].
Interestingly, and somewhat surprisingly, these “open-aperture”
immunoproteome studies demonstrated relatively few immunogenic pathovar-specific proteins, among them EtpA and
EatA. Taken together, these data suggest that targeting these 2
molecules could help to overcome some of the hurdles inherent
Molecular Pathogenesis of ETEC • jid 2021:224 (Suppl 7) • S815
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UTILITY OF INTESTINAL ORGANOIDS AS A NOVEL
MODEL IN VITRO SYSTEM FOR ETEC PATHOGENESIS

Seminal studies by Hans Clevers and his laboratory in the
Netherlands defined the signals required to maintain and
propagate intestinal epithelial cells from stem cells [28–30].
Stem cells obtained from biopsies performed during routine
endoscopic procedures can now be preserved, expanded, and
differentiated to recapitulate many of the features of normal
human intestinal epithelia normally encountered by the bacteria. Unlike transformed cells derived from gastrointestinal
malignant neoplasms, which have been widely used in the past
to study ETEC pathogen-host interactions, intestinal organoids

A

B

*
500 nm

C

500 nm

D

200 nm
Figure 2. A, Transmission electron microscopic image of enterotoxigenic Escherichia coli (ETEC) adhering to the apical surface of small-intestinal enteroids derived from
human ileum. B, ETEC (asterisk) is shown in cross-section, approaching an enterocyte flanked by 2 goblet cells that have released mucin (arrows). C, ETEC adhering to the
apical surface of small-intestinal enteroids in regions of CEACAM6 expression. D, ETEC (H10407 strain; isolated from a patient with choleralike diarrhea in Bangladesh)
adhering to the brush border formed by microvilli on the surface of small-intestinal enteroids propagated from a human (blood group A+) small intestine (scanning electron
microscopy; original magnification ×27 700).
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reflect the population of cells normally present in the intestinal
epithelium, including Paneth cells, goblet cells, enteroendocrine
cells, and, importantly, enterocytes with a well-defined brush
border and glycocalyx (Figure 2A). Importantly, with access to
large biobanks of cells from multiple individuals, rigorous data
can now be generated and the importance of features unique to
the original host can be examined in detail.
These small-intestinal “enteroid” systems have already
proved to be extraordinarily useful in exploring pathogen-host
interactions. Their ability to recapitulate important features of
human biology is illustrated in experiments showing that ETEC
deliver toxins more efficiently to blood group A enterocytes,
reflecting increased disease severity in human volunteers and
naturally infected children who express blood group A antigens
[20].
In addition, goblet cells present in the enteroids produce significant amounts of MUC2 mucin, which normally serves as a
protective barrier to mitigate interaction of ETEC with enterocytes goblet cells (Figure 2B). Data emerging from experiments
with small-intestinal enteroids as well as with surgical explants
of human small intestine demonstrate that EatA plays a critical
role, by eliminating this protective barrier to permit access of
the bacteria to the surface of enterocytes, where they can adhere
and deliver their toxin payloads.

in targeting the less highly conserved CF antigens. Molecular
epidemiology of >1000 strains from disparate sources indicate
that a vaccine targeting just 2 antigens, CS6 and EtpA would
likely encompass more than three-quarters of all ETEC [21].
Studies are also underway to elucidate the molecular structure of EtpA by cryoelectron microscopy, map the antibody responses onto the antigen, and determine the functional activity
of monoclonal antibodies which recognize specific epitopes.
These collaborative “structural vaccinology” efforts should facilitate the identification of critical regions of this large (approximately 170-kD) molecule to target in a polyvalent vaccine.

ENIGMATIC SEQUELAE ASSOCIATED WITH ETEC
INFECTION

AN EXPANDED ROLE FOR TOXINS

Notably, both ETEC enterotoxins target intestinal epithelia to
activate the production of cyclic nucleotides that serve as major
cellular “second messengers” involved in the modulation of
multiple cellular pathways. Soon after the discovery of LT, it was
recognized that it stimulates the production of cyclic adenosine
monophosphate (cAMP) by adenylate cyclase [36]. Intracellular
accumulation of cAMP leads to activation of the protein kinase
A heterotetramer by liberating its 2 catalytic subunits from regulatory subunits. The catalytic protein kinase A subunits are
then free to phosphorylate cellular targets, including chloride
and sodium ion channels, to modulate their activity, resulting
in the net release of salt and water into the lumen of the small
intestine. In addition, the free catalytic subunits also move into
the nucleus. where they phosphorylate and activate the cAMP
response element binding protein (CREB) transcription factor.

ETEC TOXINS AS POSSIBLE DRIVERS OF
ENTEROPATHY

At a microscopic level, both tropical sprue and EED are
characterized morphologically by substantial alterations
in the small-intestinal villous architecture, characterized
by blunting of the villi. The epithelial surface of intestinal
villi is comprised of enterocytes, goblet cells, tuft cells, and
enteroendocrine cells that differentiate as they propagate
up the villus surface from progenitor cells in the crypts of
Lieberkuhn, where intestinal stem cells and Paneth cells
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While the mortality rate associated with acute diarrheal diseases has declined appreciably since the introduction of oral
rehydration therapy and other measures, even less severe episodes of ETEC diarrhea can exert lasting effects on children,
including growth faltering, and malnutrition [31]. Although
ETEC, as well as other pathogens, have been repeatedly linked
to these sequelae in children, the molecular events underlying
these nondiarrheal conditions collectively referred to as environmental enteric dysfunction (EED) or environmental enteropathy, remain very poorly understood.
Interestingly, another enigmatic condition linked to toxinproducing E. coli, tropical sprue, remains the most common
cause of chronic small-intestinal malabsorption and diarrhea in areas of high ETEC prevalence including India [32].
Notably, multiple studies in the 1970s identified “toxin producing E. coli” in luminal aspirates from patients with tropical sprue [33]. Unfortunately, these studies relied on rabbit
ileal loops to demonstrate enterotoxin production, and we
lack definitive molecular characterization of isolates from
these patients.
Both EED and tropical sprue are characterized by shortening of the small-intestinal villi, lengthened crypts, mucosal
inflammation, and nutrient malabsorption [34]. Despite these
common features and epidemiologic associations connecting
these nondiarrheal sequelae to ETEC, we lack a molecular understanding of how these pathogens might promote the development of intestinal changes characteristic of enteropathy, or
whether ETEC alone are sufficient to elicit them in addition to
causing diarrhea. Essentially, we have yet to fulfill “molecular
Koch’s postulates”[35] that firmly establish ETEC as the causative agents.

Binding of CREB to CRE sites in promotor regions can potentially modulate the activity of thousands of genes [37].
Similarly, ST, binds to guanylate cyclase C on the surface of intestinal epithelial cells, where it activates production of cyclic guanosine monophosphate, to activate protein kinase G, which in turn
can phosphorylate multiple cellular proteins in addition to those directly related to modulation of ion channels and development of diarrhea. Remarkably, however, despite the capacity for these toxins to
induce pleiotropic effects on the host cell via their impact on critical
“second messenger” [38], pathways, we presently have very little information regarding other potential effects that LT- and ST-induced
signaling may have on the host, other than diarrhea.
Interestingly, LT was previously shown to play an important role in promoting ETEC adhesion to intestinal epithelial
cells in vitro [39] and small-intestinal colonization in animal
models [40, 41]. More recent investigations demonstrate that
intracellular increases in cAMP lead to enhanced production
of a number of glycoproteins known as Carcinoembryonic
Cell Adhesion Molecules (CEACAMs), expressed on the surface of small-intestinal epithelial cells [42]. These proteins,
in particular CEACAM6 (Figure 2C), then serve as receptors
for FimH, the tip adhesin molecule expressed at the ends of
chromosomally encoded type 1 pili [9]. In effect, ETEC use the
plasmid-encoded LT to change the surface architecture of target
host enterocytes, enhancing production of their own receptor.
While these events transiently benefit the pathogen, these architectural changes may come at the expense of the host, as they
are occurring on the surface of enterocytes, the major site of nutrient absorption in the human small intestine. Enterocytes are
propagated from stem cells in the small-intestinal crypts, and they
migrate to the distal end of small-intestinal villi as they mature,
eventually being released from the extracellular matrix and shed
from the villus tip to undergo programmed cell death, or anoikis
[43], a process inhibited by deregulated CEACAM6 expression
[44]. Alteration of this normal homeostatic mechanism of intestinal villi could ultimately prove to be detrimental to the host.
Conversely, enhanced expression of CEACAMs by the epithelia
could also prove to be important as a host defense strategy, as large
amounts of CEACAMs shed in stool [45] could serve as molecular
decoys that mitigate binding of ETEC to intestinal epithelia.

FUTURE DIRECTIONS

Unfortunately, in the absence of a broadly protective vaccine,
young children in low-middle-income countries will likely continue to bear the burden of acute diarrheal illness imposed on
them by ETEC. Resolving the role of more recently discovered
virulence proteins in the molecular pathogenesis of ETEC may
focus vaccine development on antigens that encompass the
breadth of ETEC.
While ETEC have been epidemiology linked to development
of sequelae including malnutrition, additional study is needed
at the molecular level to understand how these pathogens might
promote changes in the small-intestinal architecture that underlie the sequelae. It is becoming clear, however, that one or
S818  • jid 2021:224 (Suppl 7) • Fleckenstein et al

both toxins secreted by ETEC can affect a variety of cellular
pathways that govern normal homeostasis and ultimately absorptive capacity of the small intestine in addition to causing
diarrhea. An ideal ETEC vaccine would mitigate or prevent
both the acute diarrheal illness caused by ETEC, as well as the
substantial burden of nondiarrheal morbidity linked to these
pathogens.
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